Back to Case Studies
PharmaBrain: Chatbot for Medical News Documents
Health & FitnessJanuary 2024

PharmaBrain: Chatbot for Medical News Documents

Atacana needed a secure, offline medical chatbot capable of answering complex queries based on thousands of daily updated proprietary medical news reports and drug discovery advancements.

Client

Atacana

Visit Website

Year

2024

Location

Global

Domain

Generative AI

The Challenge

In the rapidly evolving pharmaceutical landscape, staying updated on medical advancements is a massive logistical challenge. Atacana required a solution that could synthesize information from thousands of documents—news reports, clinical trial updates, and drug discovery announcements—that were being added to their database daily.

The primary challenge was data privacy and the sheer volume of information. The solution required a completely offline deployment on local servers to protect proprietary medical data, while maintaining the processing speed necessary to handle thousands of daily document updates.

Our Solution

We engineered 'PharmaBrain' using a Retrieval-Augmented Generation (RAG) architecture built on a quantized Mixtral 8x7B model. By implementing 8-bit quantization, we reduced the memory footprint and processing time, enabling 5-7 second response latencies on local hardware.

Mixtral MoE Architecture

Built on a 46.7B parameter model that only uses 12.9B per token, providing significant speed advantages over comparable dense models.

LangChain Integration

Connected the LLM to the medical document database via LangChain, ensuring every answer is grounded in the latest research.

8-bit Quantization

Quantized to 8-bit to optimize for local server processing, achieving response times under 7 seconds.

Offline Security

Deployed entirely on local servers, guaranteeing zero proprietary medical data leakage to the cloud.

The Impact

The implementation of PharmaBrain has turned a static document repository into a real-time intelligence hub. Despite running locally, the system provides cited, accurate summaries of medical developments in under 7 seconds.

Performance

5-7 Seconds

Average response for RAG queries.

Compliance

100% Offline

Zero data exposure to public internet.

Project Showcase

System Performance Comparison

#User QuestionAI ResponseExpected Response
1When did Sobi acquired of CTI BioPharma Corp.?"Sobi acquired CTI BioPharma Corp. in June 2023."Sobi announced CTI BioPharma acquisition on 10 May 2023 and completed of on 26 Jun 2023
2What are the latest updates from the Ph3 PACIFICA trial?"The completion date for the Phase 3 PACIFICA trial is expected to be by the end of 2026."Sobi mentioned that the enrollment in the confirmatory Ph3 PACIFICA trial is projected to be completed by the end of 2026
3When will the Imetelstat Ph3 IMpactMF clinical trial interim and final analysis is expected?"The Imetelstat Ph3 IMpactMF clinical trial is expected to have an interim analysis in 2024, and a final analysis in 2025."Interim analysis expected in H1 2025 and final analysis expected in H1 2026
Demonstrating: AI is giving accurate responses compared to clinical benchmarks.
Book Custom AI Strategy Session

Start Your AI Consulting Services Partnership

Ready to take the first step towards unlocking opportunities, realizing goals, and embracing innovation? We're here and eager to connect.

Phone

+1 (737) 381-3933

Phone

+92 (314) 424-5425

USA

5900 Balcones Drive, STE 100 Austin TX 78731

Pakistan

585-H3, Johar Town, Lahore (Opp. Expo Center)

Your Success Starts Here!